The impact of MYB amplification in ACC is probably limited, as copy number gains of MYB has been reported only incidentally [16, 55] and predominantly in cases already harboring “conventional” MYB-NFIB fusion [16]. This evidence concerns the gene NFIB and adrenal cortex carcinoma.